Similarly, genotoxic stress from chemotherapy triggers de novo generation of CD90+ and CD105+ mesenchymal subsets (568), confirming that treatments does not merely select for pre-existing resistant clones but actively creates them, fundamentally reshaping tumor heterogeneity. The gene discussed is THY1; the disease is neoplasm.